George Raptis
- ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology
- ASSOCIATE PROFESSOR Obstetrics, Gynecology and Reproductive Science
Print Profile
Education
MBA, NYU-Stern School of Business
Biography
- Associate Professor of Medicine
Associate Chief Division of Hematology & Medical Oncology
Mount Sinai School of Medicine
Practice: Medical Oncology Associates
Specialty: Breast Cancer
In the News
Dr. Raptis and his work diagnosing and treating breast cancer in women and men were recently profiled in The Daily News feature The Daily Check Up. View the PDF.
In the News
Dr. Port and Dr. Raptis discuss breast cancer in The Daily News feature The Daily Check Up.View the PDF
Interests: Breast cancer risk assessment and prevention counseling; adjuvant therapies for breast cancer; treatment of metastatic breast cancer.
Awards
2009 -
Best Doctors
New York Magazine
Research
Research Summary
Dr. Raptis specializes in the research and treatment of breast diseases. He sees and treats patients with all stages of breast cancer and premalignant breast diseases. He also has an interest in patients at high risk for developing breast cancer.
His research is focused on the development of dose dense chemotherapy as a platform for the application of novel biologic therapies. Additionally, Dr. Raptis is involved in the study and development of a potential new predictive and prognostic factor for breast cancer.
As head of the Clinical Breast Cancer Program for the Division of Medical Oncology, Dr. Raptis is coordinating the development of research, teaching, patient care and community programs for the Mount Sinai School of Medicine. He serves on the Breast Health Resource Advisory Board and the East Harlem Partnership Against Cancer Steering Committee of the Mount Sinai School of Medicine. Dr. Raptis is also a current member of the alumni Development Committee and the Treasurer of the Alumni Association of the School of Medicine.
Clinical Trials
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Raptis did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
One Gustave L. Levy Place
Box 1129
New York, NY 10029
Fax: 212-876-5276
